A prevalent and three novel mutations in CYP11B1 gene identified in Chinese patients with 11-beta hydroxylase deficiency.
Manna Zhang,Yanling Liu,Shouyue Sun,Huijie Zhang,Weiqing Wang,Guang Ning,Xiaoying Li
DOI: https://doi.org/10.1016/j.jsbmb.2012.08.011
IF: 5.011
2013-01-01
The Journal of Steroid Biochemistry and Molecular Biology
Abstract:11 beta-Hydroxylase deficiency (11 beta-OHD), caused by CYP11B1 mutations, is characterized by hyporenine-mic, hypokalemic hypertension and hyperandrogenism. We identified a prevalent and three novel mutations of CYP11B1 gene in nine patients with classic 11 beta-OHD. Subjects and methods: Nine patients with 11 beta-OHD from unrelated families were recruited. The complications of 11 beta-OHD occurred in three patients who never received glucocorticoid treatment. CYP11B1 gene was sequenced and 11 beta-hydroxylase enzymatic activities were assessed in vitro. A haplotype analysis was performed to determine a common ancestor for those subjects who carried the same p.R454C mutation. Results: CYP11B1 gene mutations were identified in all patients, with a prevalent (p.R454C) and three novel mutations (p.V148G, IVS7-9C>A, c.1359_1360insG). The p.R141X, p.V148G, c.1359_1360insG and p.R454C mutations retained 4.9%, 3.9%, 3.7%, 4.5% of residual enzymatic activity, respectively. Five of nine patients carried p.R454C mutation, which was only reported in Chinese 11OHD patients. Haplotype analysis showed that this mutation might be inherited from a common ancestor. Conclusion: The enzymatic activities for p.R141X, p.V148G, c.1359_1360insG and p.R454C mutants were almost completely abolished, which corresponds to classic form of 11 beta-OHD. The observations of a prevalent mutation and three novel mutations might have potential clinical utility for genetic counseling and prenatal diagnosis in Chinese 11 beta-OHD patients. (C) 2012 Elsevier Ltd. All rights reserved.